PL02.01 Durvalumab ± Tremelimumab + Chemotherapy as First-line Treatment for mNSCLC: Results from the Phase 3 POSEIDON Study

Melissa L. Johnson, Byoung Chul Cho, Alexander Luft, Jorge Alatorre-Alexander, Sarayut Lucien Geater, Alexey E. Vasiliev, Dmytro Trukhin, Sujeong Kim, G. Ursol, Maen Hussein,

Journal of Thoracic Oncology · 2021 · 50 citations · 0 references

DOIFull text

Open access

Concepts